---
figid: PMC4632748__ijms-16-24243-g007
figtitle: Possible involvement of candidate microRNAs in tamoxifen resistance pathways,
  based on the present literature search and IPA analysis
organisms:
- Homo sapiens
- Mus musculus
- Sequoia sempervirens
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC4632748
filename: ijms-16-24243-g007.jpg
figlink: /pmc/articles/PMC4632748/figure/ijms-16-24243-f007/
number: F7
caption: 'Overview of the possible involvement of candidate microRNAs in tamoxifen
  resistance pathways, based on the present literature search and IPA analysis. MicroRNAs
  miR-10a, -26a, -30c, -126, -210, -342-5p and -519a and their direct (pink lines)
  or indirect (dotted lines) targets. BCL2: B-cell CLL/lymphoma 2; CDK6: cyclin-dependent
  kinase 6; CYP24A1: cytochrome P450, family 24, subfamily A, polypeptide 1; IGF1:
  insulin-like growth factor 1; FOXA1: forkhead box A1; HOXA1: homeobox A1; HOXB1:
  homeobox B1; Hsp90: heat-shock protein 90. KDM3A: lysine (K)-specific demethylase
  3A. PAG1: phosphoprotein membrane anchor with glycosphingolipid microdomains 1;
  PI3K: phosphoinositide 3-kinase; PIK3CA: phosphatidylinositol-4,5-bisphosphate 3-kinase,
  catalytic subunit alpha; PIK3CD: phosphatidylinositol-4,5-bisphosphate 3-kinase,
  catalytic subunit delta; PIK3R2: phosphoinositide-3-kinase, regulatory subunit 2
  (beta); RB1: retinoblastoma 1; TIMP3: TIMP metallopeptidase inhibitor 3; ZEB1: zinc
  finger E-box binding homeobox 1. Black arrow: normal pathway. Blue arrow: tamoxifen
  pathway. Crossed arrow: disrupted pathway. Pink inhibition arrow: direct inhibition
  by miRNA. Dotted pink inhibition arrow: indirect inhibition by miRNA.'
papertitle: The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment
  in Breast Cancer Patients.
reftext: Nina G. Egeland, et al. Int J Mol Sci. 2015 Oct;16(10):24243-24275.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9639137
figid_alias: PMC4632748__F7
figtype: Figure
redirect_from: /figures/PMC4632748__F7
ndex: 48d0c35e-ded6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4632748__ijms-16-24243-g007.html
  '@type': Dataset
  description: 'Overview of the possible involvement of candidate microRNAs in tamoxifen
    resistance pathways, based on the present literature search and IPA analysis.
    MicroRNAs miR-10a, -26a, -30c, -126, -210, -342-5p and -519a and their direct
    (pink lines) or indirect (dotted lines) targets. BCL2: B-cell CLL/lymphoma 2;
    CDK6: cyclin-dependent kinase 6; CYP24A1: cytochrome P450, family 24, subfamily
    A, polypeptide 1; IGF1: insulin-like growth factor 1; FOXA1: forkhead box A1;
    HOXA1: homeobox A1; HOXB1: homeobox B1; Hsp90: heat-shock protein 90. KDM3A: lysine
    (K)-specific demethylase 3A. PAG1: phosphoprotein membrane anchor with glycosphingolipid
    microdomains 1; PI3K: phosphoinositide 3-kinase; PIK3CA: phosphatidylinositol-4,5-bisphosphate
    3-kinase, catalytic subunit alpha; PIK3CD: phosphatidylinositol-4,5-bisphosphate
    3-kinase, catalytic subunit delta; PIK3R2: phosphoinositide-3-kinase, regulatory
    subunit 2 (beta); RB1: retinoblastoma 1; TIMP3: TIMP metallopeptidase inhibitor
    3; ZEB1: zinc finger E-box binding homeobox 1. Black arrow: normal pathway. Blue
    arrow: tamoxifen pathway. Crossed arrow: disrupted pathway. Pink inhibition arrow:
    direct inhibition by miRNA. Dotted pink inhibition arrow: indirect inhibition
    by miRNA.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir26a-1
  - Egfr
  - Erbb2
  - Timp3
  - Igf1
  - Src
  - Pelp1
  - Ptk2
  - Gper1
  - Pik3r1
  - Pag1
  - Pappa
  - ras
  - Hras
  - Kras
  - Rem1
  - Mir126a
  - Ephb2
  - Mapk1
  - Akt1
  - Mir10a
  - Cdk6
  - Mir210
  - Pik3cd
  - Pik3r2
  - Hsp90ab1
  - Hsp90aa1
  - Hsp84-2
  - Hsp84-3
  - Hsp86-ps2
  - Hsp86-ps1
  - Pik3ca
  - Bcl2
  - Cyp24a1
  - H3
  - Hoxb1
  - Foxa1
  - Mir342
  - Hoxa1
  - Zeb1
  - Kdm3a
  - MIR26A1
  - EGFR
  - ERBB2
  - IGF1R
  - TIMP3
  - IGF1
  - SRC
  - FGR
  - FYN
  - YES1
  - PELP1
  - PTK2
  - GPER1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PAG1
  - KRAS
  - HRAS
  - NRAS
  - MIR126
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - MIR10A
  - CDK6
  - MIR210
  - CLSTN1
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - BCL2
  - CYP24A1
  - HOXB1
  - FOXA1
  - MIR342
  - HOXA1
  - ZEB1
  - KDM3A
  - egfra
  - her2
  - igf1
  - dre-mir-30c
  - src
  - pelp1
  - ptk2ab
  - gper1
  - pag1
  - rab1ab
  - mir126a
  - mir10a
  - cdk6
  - mir210
  - pik3cd
  - pik3r2
  - hsp90aa1.1
  - pik3ca
  - bcl2a
  - cyp24a1
  - hoxb1a
  - foxa1
  - hoxb1b
  - hoxa1a
  - zeb1b
  - Cancer
  - Lung cancer
---
